The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Subclinical Thyroid Dysfunction and the Risk of Heart Failure in Older Persons at High Cardiovascular Risk
Open accessAbstract
CONTEXT: Subclinical thyroid dysfunction is common in older people. However, its clinical importance is uncertain. OBJECTIVE: Our objective was to determine the extent to which subclinical hyperthyroidism and hypothyroidism influence the risk of heart failure and cardiovascular diseases in older people. SETTING AND DESIGN: The Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) is an prospective cohort study. PATIENTS: Patients included men and women aged 70-82 yr (n=5316) with known cardiovascular risk factors or previous cardiovascular disease. MAIN OUTCOME MEASURES: Incidence rate of heart failure hospitalization, atrial fibrillation, and cardiovascular events and mortality according to baseline thyroid status were evaluated. Euthyroid participants (TSH=0.45-4.5 mIU/liter) were compared with those with subclinical hyperthyroidism (TSH<0.45 mIU/liter) and those with subclinical hypothyroidism (TSH≥4.5 mIU/liter, both with normal free T4). RESULTS: Subclinical hyperthyroidism was present in 71 participants and subclinical hypothyroidism in 199 participants. Over 3.2 yr follow-up, the rate of heart failure was higher for subclinical hyperthyroidism compared with euthyroidism [age- and sex-adjusted hazard ratio (HR)=2.93, 95% confidence interval (CI)=1.37-6.24, P=0.005; multivariate-adjusted HR=3.27, 95% CI=1.52-7.02, P=0.002). Subclinical hypothyroidism (only at threshold>10 mIU/liter) was associated with heart failure (age- and sex-adjusted HR=3.01, 95% CI=1.12-8.11, P=0.029; multivariate HR=2.28, 95% CI=0.84-6.23). There were no strong evidence of an association between subclinical thyroid dysfunction and cardiovascular events or mortality, except in those with TSH below 0.1 or over 10 mIU/liter and not taking pravastatin. CONCLUSION: Older people at high cardiovascular risk with low or very high TSH along with normal free T4 appear at increased risk of incident heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cardiovascular morbidity and mortality are particularly increased in men, in elderly patients with high-normal FT 4 levels and in patients with underlying heart disease [71-73, 76, 77, 87, 91, 92, 94] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [76]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The risk of HF was increased in the Prospective Study of Pravastatin (PROSPER Study) in elderly patients with a history of cardiovascular disease [76] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [76]
Experimental — accuracy not yet measuredIn the citing paper
“Some of these studies, including the meta-analyses, have also examined nonfatal cardiovascular events in SH, with similar increased risks (383,388,390,391).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [383]
In the citing paper
“Some other, smaller studies have reached similar conclusions (374,383), although other smaller studies have failed to find a correlation (380,381,384,386).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [383]
In the citing paper
“Some studies report increased overall mortality rates in SH subjects (374,379-383), especially older subjects, while others indicate no relation (384)(385)(386)(387).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [383]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
Self-citationSubclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800
Klein, I., & Danzi, S. (2007) · Circulation · doi:10.1161/circulationaha.106.678326 · Cited by 1,324
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259
Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
Rodondi, N., den Elzen, W. P. J., Bauer, D. C., Cappola, A. R., Razvi, S., Walsh, J. P., Åsvold, B. O., Iervasi, G., Imaizumi, M., Collet, T.-H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1361 · Cited by 1,216
Self-citationThyroid Status, Disability and Cognitive Function, and Survival in Old Age
Gussekloo, J. (2004) · JAMA · doi:10.1001/jama.292.21.2591 · Cited by 899
Self-citationThyroid Status, Cardiovascular Risk, and Mortality in Older Adults
Cappola, A. R., Fried, L. P., Arnold, A. M., Danese, M. D., Kuller, L. H., Burke, G. L., Tracy, R. P., & Ladenson, P. W. (2006) · JAMA · doi:10.1001/jama.295.9.1033 · Cited by 862
Parle, J. V., Maisonneuve, P., Sheppard, M. C., Boyle, P., & Franklyn, J. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06067-6 · Cited by 669
Subclinical thyroid dysfunction as a risk factor for cardiovascular disease
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2467 · Cited by 536
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 210
A practical contemporary approach to decision-making on subclinical hypothyroidism
Sgarbi, J. A., & Ward, L. S. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000317 · Cited by 15
Abbey, E. J., McGready, J., Ferrucci, L., Simonsick, E. M., & Mammen, J. S. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17015 · Cited by 12
Barasch, E., Gottdiener, J. S., Bůžková, P., Cappola, A. R., Shah, S. J., deFilippi, C. R., Gardin, J. M., & Kizer, J. R. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae001 · Cited by 11
Both experimental hypothyroidism and hyperthyroidism increase cardiac irisin levels in rats
Atıcı, E., Menevşe, E., Baltacı, A. K., & Moğulkoç, R. (2018) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2018_007 · Cited by 11
Association between the use of allopurinol and risk of increased thyroid-stimulating hormone level
Choi, W., Yang, Y.-S., Chang, D. J., Chung, Y. W., Kim, H., Ko, S. J., Yoo, S., Oh, J. S., Kang, D. Y., Yang, H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-98954-1 · Cited by 11
Hormonal profile in patients with dilated cardiomyopathy
Naderi, N., Heidarali, M., Barzegari, F., Ghadrdoost, B., Amin, A., & Taghavi, S. (2015) · Research in Cardiovascular Medicine · doi:10.5812/cardiovascmed.27631v2 · Cited by 11
Pre-admission TSH levels predict long-term mortality in adults treated for hypothyroidism
Akirov, A., Shochat, T., Shechvitz, A., Shimon, I., Diker-Cohen, T., & Robenshtok, E. (2017) · Endocrine · doi:10.1007/s12020-017-1453-8 · Cited by 10
Raguthu, C. C., Gajjela, H., Kela, I., Kakarala, C. L., Hassan, M., Belavadi, R., Gudigopuram, S. V. R., & Sange, I. (2022) · Cureus · doi:10.7759/cureus.21213 · Cited by 11
Díez, J. J., & Iglesias, P. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2014-4589 · Cited by 10
Thyroid Nodule: Current Evaluation and Management
Parsa, A. A., & Gharib, H. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_33 · Cited by 10
Golledge, J., Hankey, G. J., Almeida, O. P., Flicker, L. A., Norman, P. E., & Yeap, B. B. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.10.100 · Cited by 10
Li, X., Yao, Y., Chen, Z., Fan, S., Hua, W., Zhang, S., & Fan, X. (2018) · Clinical Cardiology · doi:10.1002/clc.23117 · Cited by 10
Alghalayini, K. W. (2015) · PubMed · Cited by 9
Hypothyroidism and Heart Failure: Epidemiology, Pathogenetic Mechanisms & Therapeutic Rationale
Francois, J. C., Al‐Sadawi, M., Casillas, J. A., Botti, E., Soni, L., Ponse, D., Decamps, S., & McFarlane, S. I. (2020) · International Journal of Clinical Research & Trials · doi:10.15344/2456-8007/2020/146 · Cited by 10
Thyroid dysfunction on the heart: clinical effects, prognostic impact and management strategies
Mattesi, G., Michele, S. D., Mele, D., Rigato, I., Bariani, R., Fiorencis, A., Previtero, M., Sergani, A. A., Leoni, L., Bauce, B., et al. (2022) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2022.2145 · Cited by 8
Airapetian, A. A., Lazareva, N. V., Reitblat, O. M., Михайлович, М. Е., Evgeny, E. V., Prints, I. S., Жиров, И. В., Tereshchenko, S. N., & Boytsov, S. A. (2023) · Consilium Medicum · doi:10.26442/20751753.2023.10.202384 · Cited by 8
Association between serum TSH concentration and bone mineral density: an umbrella review
Dziedzic, M., Bonczar, M., Ostrowski, P., Stachera, B., Plutecki, D., Buziak‐Bereza, M., Hubalewska–Dydejczyk, A., Walocha, J. A., & Koziej, M. (2024) · HORMONES · doi:10.1007/s42000-024-00555-w · Cited by 8
Feng, S., Lin, S., Zou, J., Wang, Y., Ji, Q., & Lv, Z. (2015) · International Journal of Endocrinology · doi:10.1155/2015/250542 · Cited by 7
Zhang, X., Zhang, G., Wang, S., Jin, J., Zhang, S., & Teng, X. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01754-7 · Cited by 7
Is subclinical hypothyroidism associated with cardiovascular disease in the elderly?
Yamamoto, K., Nakano, Y., Soejima, Y., Suyama, A., Oguni, K., Hasegawa, K., & Otsuka, F. (2025) · Endocrine Connections · doi:10.1530/ec-24-0601 · Cited by 8
Shin, K., Kim, J., Park, J. M., Oh, T. J., Kong, S. H., Ahn, C. H., Moon, J. H., Kim, M. J., & Moon, J. H. (2023) · Scientific Reports · doi:10.1038/s41598-023-48199-x · Cited by 7
Subclinical Hyperthyroidism and Cardiovascular Risk
Palmeiro, C., Davila, M. I., Bhat, M., Frishman, W. H., & Weiss, I. A. (2013) · Cardiology in Review · doi:10.1097/crd.0b013e318294f6f1 · Cited by 7
Reversible morbidity markers in subclinical hypothyroidism
Hennessey, J. V., & Espaillat, R. (2014) · Postgraduate Medicine · doi:10.1080/00325481.2015.998158 · Cited by 7
Hypothyroidism and related diseases: a methodological quality assessment of meta-analysis
Tian, L., Shao, F., Qin, Y., Guo, Q., & Gao, C. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024111 · Cited by 8
Subclinical hypothyroidism in adults: Consensus statement of Indian thyroid society
Rajput, R., Bajaj, S., Kalra, P., Menon, A. S., Pillai, M. G., Ghosh, S. K., Joshi, S., Seshadri, K., Kumar, P. R. G., Jayakumar, R., et al. (2022) · Thyroid Research and Practice · doi:10.4103/trp.trp_4_23 · Cited by 7
A Stepwise Approach to the Evaluation and Treatment of Subclinicalhyperthyroidism
Mai, V. Q., & Burch, H. B. (2012) · Endocrine Practice · doi:10.4158/ep12124.ra · Cited by 6
Rodrigo, E., Barrón, C. R., Olmos, J. M., Hernández, J. L., Velasco, P. G., & Nan, D. (2012) · Medicina Clínica · doi:10.1016/j.medcli.2012.03.031 · Cited by 6
Monzani, A., Prodam, F., Bellone, S., & Bona, G. (2015) · Springer eBooks · doi:10.1007/978-3-319-19213-0_17 · Cited by 6
Lipid Profile Pitfalls in Subclinical Hypothyroidism Pathophysiology and Treatment
Nicolaou, M., & Toumba, M. (2024) · Lipidology · doi:10.3390/lipidology1020008 · Cited by 8
Investigating suspected heart failure
Kotecha, T., & Fox, K. (2013) · BMJ · doi:10.1136/bmj.f2442 · Cited by 5
Akkuş, G., Sökmen, Y., Yılmaz, M., Bekler, Ö., & Akkuş, O. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200729145100 · Cited by 5
Mazeto, G. M. F. D. S., Sgarbi, J. A., Ramos, H. E., Villagelin, D., Nogueira, C. R., Vaisman, M., Graf, H., & de Carvalho, G. A. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000545 · Cited by 7
Zhong, J., Mu, D., Zou, Y., Li, L., Cheng, X., & Qiu, L. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.11.011 · Cited by 5
Saad, M., Lacoste, A. G., Balar, P., Zhang, A., & Vittorio, T. J. (2020) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944720977742 · Cited by 5
Biondi, B. (2021) · Springer eBooks · doi:10.1007/978-3-030-63277-9_7 · Cited by 5
Yang, J., Zheng, Y., Li, C., Liu, Y., Zhou, Q., Gao, J. L., Meng, X., Zhang, K., Wang, W., Shao, C., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab855 · Cited by 4
Zhang, X., Yang, L., Jin, J., Wang, H., Zhao, B., Wang, S., Shan, Z., Teng, W., & Teng, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1242110 · Cited by 6
Erem, C., Civan, N., Coşkun, H., Menteşe, A., Suleyman, A. K., Altay, D. U., Akgul, Z., & Değer, O. (2015) · Clinical Endocrinology · doi:10.1111/cen.12955 · Cited by 5
Díez, J. J., Iglesias, P., García, A. A., Mataix, A. L., & Andreu, F. A. B. (2021) · European Geriatric Medicine · doi:10.1007/s41999-021-00544-x · Cited by 5
An update on subclinical hypothyroidism and subclinical hyperthyroidism
Fatourechi, M. M., & Fatourechi, V. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.887433 · Cited by 5
The Therapeutic Potential of Propranolol and Other Beta-Blockers in Hyperthyroidism
Szybiak, W., Miedziaszczyk, M., Szałek, E., & Łącka, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178322 · Cited by 5
The effect of glycaemic control in type 2 diabetic patients with subclinical hypothyroidism
Fu, X., Xia, H., Mao, H., Zhao, S., & Wang, Z. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0519-4 · Cited by 4
Thyroid dysfunction and the elderly patient: a primer for pharmacists.
Martin, C. M. (2012) · The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists · doi:10.4140/tcp.n.2012.682 · Cited by 2
Burger, J. R., Lubbe, M. S., Serfontein, J. H. P., & Ellis, S. M. (2017) · African Health Sciences · doi:10.4314/ahs.v17i1.12 · Cited by 4
Smallridge, R. C., Sangaralingham, L. R., Mwangi, R., Kusumoto, F. M., Houten, H. V., & Bernet, V. J. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.11.030 · Cited by 4
Karaca, Y., Karasu, M., Taşolar, H., & Evren, B. (2023) · Journal of Clinical Ultrasound · doi:10.1002/jcu.23459 · Cited by 4
Subclinical hyperthyroidism and cardiovascular manifestations: a reevaluation of the association
Carpi, A., Cini, G., Russo, M. A., Antonelli, A., Gaudio, C., Galetta, F., Franzoni, F., & Rossi, G. (2013) · Internal and Emergency Medicine · doi:10.1007/s11739-013-0913-2 · Cited by 4
Impact of Thyroid Disease on Heart Failure
Stanciu, A. E., Zamfir‐Chiru‐Anton, A., Stanciu, M., & Gheorghe, D. C. (2017) · InTech eBooks · doi:10.5772/66283 · Cited by 4
Rajão, K. M. A. B., Ribeiro, A. L. P., Passos, V. M. D. A., Benseñor, I. M., Vidigal, P. G., Camacho, C. P., & Diniz, M. D. F. H. S. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190037 · Cited by 5
Liu, L., Zhang, H., Chen, X., Liu, Z., Zhao, H.-Y., Ma, S., Zhao, M., Shen, P., Sun, Y., Lin, H., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1640086 · Cited by 4
Anagnostis, P. G., Karras, S. Ν., Gotsis, E., & Berthold, I. (2013) · The Open Hypertension Journal · doi:10.2174/1876526201305010087 · Cited by 3
Albakri, A. (2019) · Research and Review Insights · doi:10.15761/rri.1000153 · Cited by 3
Xu, Y., Hysaj, O., Qi, X., Feller, M., Pingitore, A., Brown, S. J., Ittermann, T., Iacoviello, M., Trompet, S., Han, J. W., et al. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00009-4 · Cited by 2
Self-citationAbumayyaleh, M., Akin, I., Goertz, M., Reinhardt, M., Abel, N., Schmitt, A., Lau, F., Weidner, K., Dudda, J., Steffen, H. J., et al. (2026) · Endocrine · doi:10.1007/s12020-026-04660-1 · Cited by 2
Levothyroxine in the Older Patient
Razvi, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-63277-9_6 · Cited by 2
Occurrence of Arrhythmias in Women with Thyroid Cancer Receiving Suppressive Doses of Levothyroxine
Kaziród-Wolski, K., Kowalska, A., Sielski, J. K., Biskup-Frużyńska, M., & Piotrowski, G. (2021) · Current Oncology · doi:10.3390/curroncol28060420 · Cited by 2
Zhou, H., Wang, Q., Liu, Z., Wu, G., Zhou, W., Yang, D., & Chen, K. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-024-03827-w · Cited by 2
Aging and Subclinical Thyroid Dysfunction
da Costa, C. V. M., & Rosenthal, D. (2013) · InTech eBooks · doi:10.5772/55194 · Cited by 2
Altıncık, A., Demir, K., Çatlı, G., Abacı, A., & Böber, E. (2015) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.1985 · Cited by 2
Heart in Overt and Subclinical Hypothyroidism
Biondi, B. (2020) · Springer eBooks · doi:10.1007/978-3-030-36871-5_17 · Cited by 2
Graves’ Disease and Cardiac Complications
Arslan, A., & Altay, H. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97128 · Cited by 2
Astudillo, D. L. P., Tapia, I. P. J., García, L. C. L., Solórzano, T. I. G., Huang, A. F. C. C., Lucio, Á. B. C., & Cando, D. I. G. (2024) · Ibero-American Journal of Health Science Research · doi:10.56183/iberojhr.v4is.613 · Cited by 2
Subklinische Schilddrüsenfunktionsstörungen in der Peri- und Postmenopause
Bojunga, J. (2015) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 2
Thyroid gland and heart: a cardiologist’s view on an endocrinological pathology. Review
Кondratiuk, V. Y., & Стахова, А. (2023) · Clinical endocrinology and endocrine surgery · doi:10.30978/cees-2023-3-41 · Cited by 1
Subclinical Thyroid Dysfunction and Cardiovascular Disease
Lourenço, I., Correia-Chaves, J., Leite, A. R., Borges‐Canha, M., von Hafe, M., Vale, C., Leite-Moreira, A. F., & Neves, J. S. (2023) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.26497/ar230029 · Cited by 1
Subclinical Thyroid Disorders: Clinical Significance and When to Treat?
Ng, M. C. W., Loo, Y. X., & Poon, Z. M. (2014) · Proceedings of Singapore Healthcare · doi:10.1177/201010581402300308 · Cited by 1
1. Pathophysiology and Treatment for Autoimmune Thyroid Disease
Itoh, M. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.2355 · Cited by 1
The frequency of metabolic syndrome in patients with the subclinical hypothyroidism
Mulić, M., Skrijeljm, F., Hajrović, Š., Prelevic, R. I., & Milev, B. (2016) · Vojnosanitetski pregled · doi:10.2298/vsp160519302m · Cited by 1
PREVALENCE OF SUBCLINICAL HYPOTHYROIDISM IN ELDERLY PATIENTS WITH CARDIOVASCULAR DISEASE.
Eldarawy, M. M., Rashad, N., Hammam., A., Wadea, F. M., Ibrahim, T. H., Alkolaly, A., & El-Shal, A. (2016) · International Journal of Advanced Research · doi:10.21474/ijar01/2607 · Cited by 1
Oğuz, S. H., & Yıldız, B. O. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98804-9.00029-3 · Cited by 1
Han, X., & Wang, X. (2024) · Medicine · doi:10.1097/md.0000000000038410 · Cited by 1
Treatment options of subclinical hyperthyroidism and cardiovascular risk
Kyrilli, A., Lytrivi, M., Lassen, P. B., & Corvilain, B. (2018) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2018.01.008 · Cited by 2
Din, N., Latif, A., Rahman, A. U., Ali, S., & Parvez, M. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22162278 · Cited by 1
Campanini, M., & Grandi, M. (2017) · Italian Journal of Medicine · doi:10.4081/itjm.q.2017.3 · Cited by 1
1. Pathophysiology and Treatment for Autoimmune Thyroid Disease
Itoh, M. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.127a · Cited by 1
Pearce, E. N. (2015) · Clinical Thyroidology · doi:10.1089/ct.2015;27.177-179
Subclinical thyroid disorders – Authors' reply
Cooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61243-4
Potempa, M., & Jończyk, P. (2015) · Biology and Medicine · doi:10.4172/0974-8369.1000255
Treatment for thyroid carcinoma with trachea invasion in one centenarian
Xiumei, C., Xiangrong, G., Song, R., Qingquan, Z., Xicheng, S., Zhang, H., & Wang, Q. (2014) · Chinese Medical Journal · doi:10.1097/00029330-201409200-00032
Sarkar, S. D. (2015)
Iperfunzione tiroidea nell’anziano
Pasqualetti, G., Ilacqua, A., Niccolai, F., Belfiore, A., & Monzani, F. (2016) · L Endocrinologo · doi:10.1007/s40619-016-0232-8
Guías de práctica clínica para el tratamiento del hipotiroidismo
Brenta, G., Vaisman, M., Sgarbi, J. A., de Andrada, N. C., Bravo, P. P., Orlandi, A. M., & Graf, H. (2013)
Subclinical Hypothyroidism Among Those 85+ Years Old Is Not Associated with Increased Mortality
Leung, A. M. (2017) · Clinical Thyroidology · doi:10.1089/ct.2017;29.25-27
Función tiroidea y mortalidad en pacientes ancianos hospitalizados
de la Cámara, E. R. G. (2014) · doi:10.14201/gredos.127853
Thyroxine Therapy for Thyroid Nodules
Parsa, A. A., & Gharib, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-59474-3_9
Thyroid Disorders in the Elderly
Tabatabaie, V., & Surks, M. I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95832-x
Cardiovascular Risk in Subclinical Hypothyroidism
Dobrescu, M., Păun, D. L., Grigorie, D., & Poiană, C. (2018) · Internal Medicine · doi:10.2478/inmed-2018-0022 · Cited by 1
Hemodynamics and oxygen delivery in thyroid surgery patients under total intravenous anaesthesia
Тарасенко, С. О., Кунатовський, М. В., Дубров, С. О., & Єфімова, О. О. (2018) · Clinical endocrinology and endocrine surgery · doi:10.24026/1818-1384.3(63).2018.142693
Biondi, B., & Kahaly, G. J. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_21
Thyroid disorders in elderly people: challenges, pearls and updates
Tawfik, M. (2018) · Egyptian Journal of Geriatrics and Gerontology · doi:10.21608/ejgg.2018.30872
Soeiro, A. D. M. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190102
Afectarea cardiovasculară în hipertiroidism
Universitatea de Medicină şi Farmacie „Carol Davila“, B., Voiculescu, D., Busnatu, Ș., Universitatea de Medicină şi Farmacie „Carol Davila“, B., Dimitriu, I., Universitatea de Medicină şi Farmacie „Carol Davila“, B., Sinescu, C. J., & Universitatea de Medicină şi Farmacie „Carol Davila“, B. (2019) · Romanian Medical Journal · doi:10.37897/rmj.2019.3.14
SUBCLINICAL HYPOTHYROIDISM CURRENT CONCEPTS & M ANAGEMENT STRATEGEIES
Radha Krishnan, D., Soumini, G., & Adithya, M. G. V. (2015) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2015/425
Швед, М. І., Heryak, S. N., Kyrychok, I., Kitsak, Y. M., & Boyko, T. V. (2018) · Likarska sprava · doi:10.31640/ls-2017-8-03
Brenta, G., & Sgarbi, J. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_24
Sarkar, S. D. (2014) · Springer eBooks · doi:10.1007/978-3-319-06112-2_7
Hipotiroidismo subclínico e risco cardiovascular em mulheres idosas
Peterson, J. C. B. (2012) · doi:10.47749/t/unicamp.2012.872398
Hassan, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-25871-3_10
Metadata
- Authors
- Nanchen, D., Gussekloo, J., Westendorp, R. G. J., Stott, D. J., Jukema, J. W., Trompet, S., Ford, I., Welsh, P., Sattar, N., Macfarlane, P. W., Mooijaart, S. P., Rodondi, N., de Craen, A. J. M., & on behalf of the PROSPER Group
- Affiliations
- Leiden University Medical Center (NL)
- Department of Public Health and Primary Care (J.G.), 2333 ZA Leiden, The Netherlands
- University of Glasgow (GB)
- Department of Cardiology (J.W.J.), 2333 ZA Leiden, The Netherlands
- Robertson Centre for Biostatistics (I.F.), Glasgow G12 8QQ, United Kingdom
- University of Bern (CH)
- Leiden University Medical Center, Department of Gerontology and Geriatrics (D.N., R.G.J.W., S.T., S.P.M., A.J.M.d.C.), 2333 ZA Leiden, The Netherlands
- Corresponding author
- Nanchen, David
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-03-01
- Volume
- 97
- Issue
- 3
- Pages
- 852-861
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2110776403
- Cited by
- 211
- References
- 34
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 11 · 2023: 13 · 2022: 15 · 2021: 14 · 2020: 9 · 2019: 15 · 2018: 12 · 2017: 22 · 2016: 11 · 2015: 25 · 2014: 13 · 2013: 25 · 2012: 14
- FWCI
- 19.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Science Foundation
- Bristol-Myers Squibb
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (132943, 138267, 320030)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (050.060.810, 05040202)
- Université de Lausanne
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- subclinical hyperthyroidism, subclinical hypothyroidism, subclinical thyroid dysfunction, heart failure, heart failure hospitalization, older adults, cardiovascular risk, thyroid-stimulating hormone, atrial fibrillation, cardiovascular events, mortality, pravastatin, free thyroxine, TSH suppression therapy, statin therapy
- MeSH terms
- Aged, Aged, 80 and over, Atrial Fibrillation, Cardiovascular Diseases, Female, Follow-Up Studies, Heart Failure, Humans, Male, Prospective Studies, Risk, Risk Factors, Thyroid Diseases, Survival Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
